The Patent Finder
US

Antibody Molecules to TIM-3 and Uses Thereof

US 10,981,990 In force
OverviewFamilyAssignmentsSources & methods

Term ends Jan 30, 2035 · High confidence

Held by Novartis AG
Filed Apr 6, 2020 as application 16/841,029 · Granted Apr 20, 2021
Base term, 20 years from filing
Today
20 years from filing
2015 2035
Clock starts
Jan 30, 2015
Term ends
Jan 30, 2035
Granted
Apr 20, 2021
base term fee events Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 9,605,070, to Jan 30, 2035. The term already ends on or before that date, so the cap shortened nothing.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
6
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 1 of 3 maintenance fees is paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Jan 30, 2015, when application 14/610,837, the earliest non-provisional in its chain, was filed (this one was filed Apr 6, 2020)Jan 30, 2035High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 9,605,070)resolves to Jan 30, 2035, no earlier than this term, so no changeHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events1 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderJan 30, 2035High confidence

This family

US 9,605,070In force
Jan 2035
Jan 2035
US 10,472,419In force
Jan 2035
Jan 2035
US 9,884,913In force
Jan 2035
Jan 2035
US 11,155,620In force
Feb 2035
Feb 2035
US 10,981,990this patent
Jan 2035
Jan 2035
Application 17/484,794Abandoned
not computed
not computed
The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Jul 28, 2020
Reel 53332, frame 165
Freeman, Gordon JamesDana-Farber Cancer Institute, Inc.Assignment of Assignor's Interest
Jul 28, 2020
Reel 53333, frame 461
Dekruyff, Rosemarie H.; Umetsu, Dale T.Children's Medical Center CorporationAssignment of Assignor's Interest
Jul 28, 2020
Reel 53333, frame 481
Vasquez, MaximilianoGalaxy Biotech, LLCAssignment of Assignor's Interest
Jul 28, 2020
Reel 53333, frame 489
Brannetti, Barbara; Huber, Thomas; Pietzonka, ThomasNovartis Pharma AGAssignment of Assignor's Interest
Jul 28, 2020
Reel 53333, frame 529
Sabatos-peyton, Catherine Anne; Mataraza, Jennifer Marie; Blattler, Walter A.; Hicklin, Daniel J.Costim Pharmaceuticals Inc.Assignment of Assignor's Interest
Jul 28, 2020
Reel 53333, frame 568
Harris, Alan S.Novartis Institutes for Biomedical Research, Inc.Assignment of Assignor's Interest
Jul 28, 2020
Reel 53333, frame 586
Hu, Tiancen; Taraszka, John A.; Xu, FangminNovartis Institutes for Biomedical Research, Inc.Assignment of Assignor's Interest
Jul 28, 2020
Reel 53333, frame 611
Galaxy Biotech, LLCCostim Pharmaceuticals Inc.Assignment of Assignor's Interest
Jul 28, 2020
Reel 53333, frame 624
Costim Pharmaceuticals Inc.Novartis AGAssignment of Assignor's Interest
Jul 28, 2020
Reel 53333, frame 643
Novartis Institutes for Biomedical Research, Inc.Novartis AGAssignment of Assignor's Interest
Jul 28, 2020
Reel 53333, frame 648
Novartis Pharma AGNovartis AGAssignment of Assignor's Interest
Jan 29, 2024
Reel 66377, frame 855
Dana-Farber Cancer InstNational Institutes of Health (Nih), U.S. Dept. of Health and Human Services (DHHS), U.S. GovernmentConfirmatory License

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited